Shallcross Steven a, Senior VP, CFO, Treasurer at Vanda Pharmaceuticals Inc. (VNDA), sold 3,200 shares at $25.63 ($81K) on 2007-01-16, disclosed to the SEC on 2007-01-18.
Scheduled sale ($81k) by Senior VP, CFO, Treasurer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.11 | 460 | $12K | 14.2% |
| 2 | $25.20 | 300 | $8K | 9.3% |
| 3 | $25.20 | 700 | $18K | 21.8% |
| 4 | $25.31 | 600 | $15K | 18.7% |
| 5 | $25.35 | 100 | $3K | 3.1% |
| 6 | $25.37 | 100 |
| $3K |
| 3.1% |
| 7 | $25.45 | 100 | $3K | 3.1% |
| 8 | $25.59 | 100 | $3K | 3.2% |
| 9 | $25.60 | 140 | $4K | 4.4% |
| 10 | $25.63 | 400 | $10K | 12.6% |
| 11 | $25.63 | 100 | $3K | 3.2% |
| 12 | $25.60 | 100 | $3K | 3.2% |
| Total | $25.33 avg | 3,200 | $81K | 100% |
| Filing → |
| TOVX | BUY | 2023-02-13 | $26K | — | Filing → |
| TOVX | BUY | 2023-02-03 | $24K | — | Filing → |
| TOVX | BUY | 2023-01-26 | $22K | — | Filing → |